Abstract
Background: Although clinicians failed to reproduce Pauling and Cameron’s earlier reports on the therapeutic effects of vitamin C on cancer, new information on the pharmacokinetics and pharmacodynamics of vitamin C as well as new clinical data has provided more in depth understanding of the critical aspects of vitamin C’s therapeutic effects. Previous clinical studies suggested that vitamin C, introduced to cancer patients by intravenous and oral pathways, might improve their symptoms. Methods: This review summarizes and focuses on different pharmacological effects of vitamin C that are currently under investigation in pharmacogenomic studies related to transporter gene polymorphism. Conclusion: From the information available, it seems clear that vitamin C is involved in a variety of disease mechanisms. This review might provide an evaluation of vitamin C as a personalized adjuvant medicine.
Keywords: Vitamin C, VitaminC transporter, pharmacogenomics, personalized adjuvant medicine.
Current Pharmacogenomics and Personalized Medicine
Title:Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies
Volume: 13 Issue: 1
Author(s): Seyeon Park
Affiliation:
Keywords: Vitamin C, VitaminC transporter, pharmacogenomics, personalized adjuvant medicine.
Abstract: Background: Although clinicians failed to reproduce Pauling and Cameron’s earlier reports on the therapeutic effects of vitamin C on cancer, new information on the pharmacokinetics and pharmacodynamics of vitamin C as well as new clinical data has provided more in depth understanding of the critical aspects of vitamin C’s therapeutic effects. Previous clinical studies suggested that vitamin C, introduced to cancer patients by intravenous and oral pathways, might improve their symptoms. Methods: This review summarizes and focuses on different pharmacological effects of vitamin C that are currently under investigation in pharmacogenomic studies related to transporter gene polymorphism. Conclusion: From the information available, it seems clear that vitamin C is involved in a variety of disease mechanisms. This review might provide an evaluation of vitamin C as a personalized adjuvant medicine.
Export Options
About this article
Cite this article as:
Park Seyeon, Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies, Current Pharmacogenomics and Personalized Medicine 2015; 13 (1) . https://dx.doi.org/10.2174/1875692113666150714180709
DOI https://dx.doi.org/10.2174/1875692113666150714180709 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery
Current Drug Targets Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters Implementation of “Quality by Design (QbD)” Approach for the Development of 5-Fluorouracil Loaded Thermosensitive Hydrogel
Current Drug Delivery Autophagy : Moving Benchside Promises to Patient Bedsides
Current Cancer Drug Targets Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension
Current Drug Discovery Technologies Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective
Anti-Cancer Agents in Medicinal Chemistry KSP Inhibitors as Antimitotic Agents
Current Topics in Medicinal Chemistry miR-629-3p Level Significantly Predicts Prognosis in Glioblastoma Patients Treated with Temozolomide Chemotherapy
Current Signal Transduction Therapy Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Integrin Antagonists in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Eating Green: Shining Light on the Use of Dietary Phytochemicals as a Modern Approach in the Prevention and Treatment of Head and Neck Cancers
Current Topics in Medicinal Chemistry Non-Viral Delivery of RNA Interference Targeting Cancer Cells in Cancer Gene Therapy
Current Gene Therapy Elucidation of PLK1 Linked Biomarkers in Oesophageal Cancer Cell Lines: A Step Towards Novel Signaling Pathways by p53 and PLK1-Linked Functions Crosstalk
Protein & Peptide Letters Simultaneous Quantification of Paclitaxel Prodrug and its Released Paclitaxel in Human Plasma by UPLC-MS/MS
Current Pharmaceutical Analysis The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets Proteomics of Human Pulmonary Surfactant Proteins
Current Proteomics In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Current Pharmaceutical Design